Cronos Group (CRON) vs Niagen Bioscience (NAGE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cronos Group (CRON) has outperformed Niagen Bioscience (NAGE) over the past year, gaining 23.7% versus a loss of 62.1%. Over five years, CRON leads with a -40.9% price change compared with -57.2% for NAGE. Cronos Group is the larger company by market cap ($1.18 billion vs $206.5 million), about 5.7 times the size.
On valuation, Niagen Bioscience trades at a lower trailing P/E (13.7x vs 16.9x for Cronos Group).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRON | NAGE |
|---|---|---|
| Share price | $3.21 | $2.61 |
| Market cap | $1.18B | $206.52M |
| 1-day change | -1.08% | -4.04% |
| YTD return | +23.19% | -57.23% |
| 1-year return | +23.66% | -62.12% |
| 5-year return | -40.88% | -57.23% |
| P/E ratio (TTM) | 16.87 | 13.74 |
| Forward P/E | — | 26.10 |
| EPS (TTM) | $0.19 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.61 | $7.95 |
| 52-week low | $2.28 | $2.61 |
| Distance from 52-week high | -11.17% | -67.17% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | -23.24% | +362.84% |
| Average volume | 1.13M | 585.78K |
| Shares outstanding | 368.41M | 79.13M |
| Employees | 610 | 117 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cronos Group is about 5.7 times larger than Niagen Bioscience by market value ($1.18B vs $206.52M).
- CRON has outperformed NAGE by 85.8 percentage points over the past year.
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Health Care · Medicinal Chemicals and Botanical Products · 610 employees
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
CRON vs NAGE FAQ
Which is bigger, Cronos Group or Niagen Bioscience?
Cronos Group (CRON) is larger, with a market capitalization of $1.18B compared with $206.52M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, CRON or NAGE?
CRON returned +23.66% over the past 12 months, compared with -62.12% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CRON or NAGE?
NAGE has the lower trailing P/E at 13.7, versus 16.9 for CRON. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Cronos Group and Niagen Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.